These two get lumped together constantly because they both come out of Russian research and both get described as 'nootropic' peptides, but mechanistically they seem quite different. I wanted a thread to untangle how people conceptualize them, linked to both Library pages.
My understanding: Semax is an ACTH fragment associated with BDNF modulation and gets framed more around focus and neuroprotection, while Selank is derived from tuftsin and gets framed more around anxiety and immune modulation. Most of the clinical work is Russian and not always easy to evaluate against Western trial standards.
Curious how others draw the line, and where you think the evidence is weakest.